Gland Pharma's shares opened 9.5% lower on Thursday after the company reported a 20% year-on-year decline in profit at ₹241.2 crore for the September quarter. Its stock hit a 52-week low of ₹1,912/share on NSE soon after opening. At 11:24 am, it was trading 14.40% lower at ₹1,904.95/share. The fall in profit was led by weak topline and operating performance.